MONEY

Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-™T) at 2024 CSCO Congress

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 29, 2024 - 12:00
Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-™T) at 2024 CSCO Congress
Read More

Tags:

Previous Article

Inside the making—and evolution—of ‘Domo on Data’ blogs

Next Article

Argentina's Milei predicts 2025 election shakeup at party launch

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Russian strike on apartment block in Kharkiv injures 21

Russian strike on apartment block in Kharkiv injures 21

Tomas Kauer - Mode... Sep 22, 2024

OPEC+ production cut extension positive for oil prices, Wells Fargo says

OPEC+ production cut extension positive for oil prices,...

Tomas Kauer - Mode... Sep 21, 2024

BPYPP stock touches 52-week high at $16.18 amid market optimism

BPYPP stock touches 52-week high at $16.18 amid market ...

Tomas Kauer - Mode... Sep 20, 2024